593 related articles for article (PubMed ID: 21743242)
1. Why does kidney allograft fail? A long-term single-center experience.
Alarrayed S; El-Agroudy A; Al-Arrayed A; Ghareeb S; Farid E; Garadah T; Abdulla S
Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):818-24. PubMed ID: 21743242
[TBL] [Abstract][Full Text] [Related]
2. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of recipients whose kidney allograft has functioned for more than 20 years.
El-Agroudy AE; El-Dahshan KE; Abbass TM; Ismail AM; Shokeir AA; Ghoneim MA
Exp Clin Transplant; 2008 Jun; 6(2):155-60. PubMed ID: 18816244
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of long-term live-donor pediatric renal transplant survivors: a single-center experience.
El-Husseini AA; Foda MA; Osman YM; Sobh MA
Pediatr Transplant; 2006 May; 10(3):288-93. PubMed ID: 16677350
[TBL] [Abstract][Full Text] [Related]
5. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
6. Steroid withdrawal in kidney transplant recipients: is it a safe option?
Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients.
Kuo PC; Luikart H; Busse-Henry S; Hunt SA; Valantine HA; Stinson EB; Oyer PE; Scandling JD; Alfrey EJ; Dafoe DC
Clin Transplant; 1995 Apr; 9(2):92-7. PubMed ID: 7599409
[TBL] [Abstract][Full Text] [Related]
8. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
Cecka JM
Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
[TBL] [Abstract][Full Text] [Related]
10. Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data.
Joss N; Rodger RS; McMillan MA; Junor BJ
Transplantation; 2007 Mar; 83(5):582-7. PubMed ID: 17353778
[TBL] [Abstract][Full Text] [Related]
11. [Living-donor kidney transplantation in the cyclosporine era].
Campise M; Tarantino A; Berardinelli L; Finazzi S; Montagnino G; Rossini G; Scalamogna M; Cesana B; Ponticelli C
G Ital Nefrol; 2002; 19(1):49-54. PubMed ID: 12165946
[TBL] [Abstract][Full Text] [Related]
12. Superior long-term results of renal transplantation in children under 5 years of age.
Ojogho O; Sahney S; Cutler D; Abdelhalim F; Hasan M; Baron P; Concepcion W
Am Surg; 2002 Dec; 68(12):1115-9. PubMed ID: 12516821
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppression in live-related donor renal transplantation.
Iman A; Rao M; Juneja R; Jacob CK
Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
[TBL] [Abstract][Full Text] [Related]
14. Effect of early cyclosporine levels on kidney allograft rejection.
Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
[TBL] [Abstract][Full Text] [Related]
15. [Pediatric kidney transplantation and living donors--invaluable by virtue of necessity].
Leumann E; Goetschel P; Neuhaus TJ; Ambühl PM; Candinas D
Schweiz Med Wochenschr; 2000 Oct; 130(43):1581-9. PubMed ID: 11100511
[TBL] [Abstract][Full Text] [Related]
16. Preemptive living donor renal transplantation: a single-center experience.
Haberal M; Karakayali H; Sevmis S; Akbulut S; Colak T; Baskin E; Moray G; Torgay A; Arslan G
Transplant Proc; 2009 Sep; 41(7):2764-7. PubMed ID: 19765429
[TBL] [Abstract][Full Text] [Related]
17. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
[TBL] [Abstract][Full Text] [Related]
18. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
Guttmann RD; Flemming C
Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
[TBL] [Abstract][Full Text] [Related]
19. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
Mota A
Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
[TBL] [Abstract][Full Text] [Related]
20. Acute rejection and late renal transplant failure: risk factors and prognosis.
Pallardó Mateu LM; Sancho Calabuig A; Capdevila Plaza L; Franco Esteve A
Nephrol Dial Transplant; 2004 Jun; 19 Suppl 3():iii38-42. PubMed ID: 15192134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
